1 Study Coverage
1.1 Precision Cancer Tests Revenue in Precision Cancer Tests Business (2017-2022) & (US$ Million) Introduction
1.2 Global Precision Cancer Tests Outlook 2017 VS 2022 VS 2028
1.2.1 Global Precision Cancer Tests Market Size for the Year 2017-2028
1.2.2 Global Precision Cancer Tests Market Size for the Year 2017-2028
1.3 Precision Cancer Tests Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Precision Cancer Tests in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Precision Cancer Tests Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Precision Cancer Tests Market Dynamics
1.4.1 Precision Cancer Tests Industry Trends
1.4.2 Precision Cancer Tests Market Drivers
1.4.3 Precision Cancer Tests Market Challenges
1.4.4 Precision Cancer Tests Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Precision Cancer Tests by Type
2.1 Precision Cancer Tests Market Segment by Type
2.1.1 Imaging
2.1.2 In Vitro Diagnostic
2.1.3 Others
2.2 Global Precision Cancer Tests Market Size by Type (2017, 2022 & 2028)
2.3 Global Precision Cancer Tests Market Size by Type (2017-2028)
2.4 United States Precision Cancer Tests Market Size by Type (2017, 2022 & 2028)
2.5 United States Precision Cancer Tests Market Size by Type (2017-2028)
3 Precision Cancer Tests by Application
3.1 Precision Cancer Tests Market Segment by Application
3.1.1 Cancer Research Centers
3.1.2 Cancer Hospital
3.1.3 Surgical Centers
3.1.4 Clinics
3.1.5 Others
3.2 Global Precision Cancer Tests Market Size by Application (2017, 2022 & 2028)
3.3 Global Precision Cancer Tests Market Size by Application (2017-2028)
3.4 United States Precision Cancer Tests Market Size by Application (2017, 2022 & 2028)
3.5 United States Precision Cancer Tests Market Size by Application (2017-2028)
4 Global Precision Cancer Tests Competitor Landscape by Company
4.1 Global Precision Cancer Tests Market Size by Company
4.1.1 Top Global Precision Cancer Tests Companies Ranked by Revenue (2021)
4.1.2 Global Precision Cancer Tests Revenue by Player (2017-2022)
4.2 Global Precision Cancer Tests Concentration Ratio (CR)
4.2.1 Precision Cancer Tests Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Precision Cancer Tests in 2021
4.2.3 Global Precision Cancer Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Precision Cancer Tests Headquarters, Revenue in Precision Cancer Tests Business (2017-2022) & (US$ Million) Type
4.3.1 Global Precision Cancer Tests Headquarters and Area Served
4.3.2 Global Precision Cancer Tests Companies Revenue in Precision Cancer Tests Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Precision Cancer Tests Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Precision Cancer Tests Market Size by Company
4.5.1 Top Precision Cancer Tests Players in United States, Ranked by Revenue (2021)
4.5.2 United States Precision Cancer Tests Revenue by Players (2020, 2021 & 2022)
5 Global Precision Cancer Tests Market Size by Region
5.1 Global Precision Cancer Tests Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Precision Cancer Tests Market Size by Region (2017-2028)
5.2.1 Global Precision Cancer Tests Market Size by Region: 2017-2022
5.2.2 Global Precision Cancer Tests Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Precision Cancer Tests Market Size YoY Growth 2017-2028
6.1.2 North America Precision Cancer Tests Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Precision Cancer Tests Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Precision Cancer Tests Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Precision Cancer Tests Market Size YoY Growth 2017-2028
6.3.2 Europe Precision Cancer Tests Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Precision Cancer Tests Market Size YoY Growth 2017-2028
6.4.2 Latin America Precision Cancer Tests Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Precision Cancer Tests Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Precision Cancer Tests Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Company Details
7.1.2 Abbott Business Overview
7.1.3 Abbott Precision Cancer Tests Introduction
7.1.4 Abbott Revenue in Precision Cancer Tests Business (2017-2022)
7.1.5 Abbott Recent Development
7.2 BD
7.2.1 BD Company Details
7.2.2 BD Business Overview
7.2.3 BD Precision Cancer Tests Introduction
7.2.4 BD Revenue in Precision Cancer Tests Business (2017-2022)
7.2.5 BD Recent Development
7.3 Bio-Rad
7.3.1 Bio-Rad Company Details
7.3.2 Bio-Rad Business Overview
7.3.3 Bio-Rad Precision Cancer Tests Introduction
7.3.4 Bio-Rad Revenue in Precision Cancer Tests Business (2017-2022)
7.3.5 Bio-Rad Recent Development
7.4 Cynvenio Biosystems
7.4.1 Cynvenio Biosystems Company Details
7.4.2 Cynvenio Biosystems Business Overview
7.4.3 Cynvenio Biosystems Precision Cancer Tests Introduction
7.4.4 Cynvenio Biosystems Revenue in Precision Cancer Tests Business (2017-2022)
7.4.5 Cynvenio Biosystems Recent Development
7.5 Foundation Medicine
7.5.1 Foundation Medicine Company Details
7.5.2 Foundation Medicine Business Overview
7.5.3 Foundation Medicine Precision Cancer Tests Introduction
7.5.4 Foundation Medicine Revenue in Precision Cancer Tests Business (2017-2022)
7.5.5 Foundation Medicine Recent Development
7.6 Genomic Health
7.6.1 Genomic Health Company Details
7.6.2 Genomic Health Business Overview
7.6.3 Genomic Health Precision Cancer Tests Introduction
7.6.4 Genomic Health Revenue in Precision Cancer Tests Business (2017-2022)
7.6.5 Genomic Health Recent Development
7.7 Illumina
7.7.1 Illumina Company Details
7.7.2 Illumina Business Overview
7.7.3 Illumina Precision Cancer Tests Introduction
7.7.4 Illumina Revenue in Precision Cancer Tests Business (2017-2022)
7.7.5 Illumina Recent Development
7.8 Myriad Genetics
7.8.1 Myriad Genetics Company Details
7.8.2 Myriad Genetics Business Overview
7.8.3 Myriad Genetics Precision Cancer Tests Introduction
7.8.4 Myriad Genetics Revenue in Precision Cancer Tests Business (2017-2022)
7.8.5 Myriad Genetics Recent Development
7.9 NanoString Technologies
7.9.1 NanoString Technologies Company Details
7.9.2 NanoString Technologies Business Overview
7.9.3 NanoString Technologies Precision Cancer Tests Introduction
7.9.4 NanoString Technologies Revenue in Precision Cancer Tests Business (2017-2022)
7.9.5 NanoString Technologies Recent Development
7.10 QIAGEN
7.10.1 QIAGEN Company Details
7.10.2 QIAGEN Business Overview
7.10.3 QIAGEN Precision Cancer Tests Introduction
7.10.4 QIAGEN Revenue in Precision Cancer Tests Business (2017-2022)
7.10.5 QIAGEN Recent Development
7.11 Randox Laboratories
7.11.1 Randox Laboratories Company Details
7.11.2 Randox Laboratories Business Overview
7.11.3 Randox Laboratories Precision Cancer Tests Introduction
7.11.4 Randox Laboratories Revenue in Precision Cancer Tests Business (2017-2022)
7.11.5 Randox Laboratories Recent Development
7.12 Roche
7.12.1 Roche Company Details
7.12.2 Roche Business Overview
7.12.3 Roche Precision Cancer Tests Introduction
7.12.4 Roche Revenue in Precision Cancer Tests Business (2017-2022)
7.12.5 Roche Recent Development
7.13 Philips
7.13.1 Philips Company Details
7.13.2 Philips Business Overview
7.13.3 Philips Precision Cancer Tests Introduction
7.13.4 Philips Revenue in Precision Cancer Tests Business (2017-2022)
7.13.5 Philips Recent Development
7.14 Thermo Fisher Scientific
7.14.1 Thermo Fisher Scientific Company Details
7.14.2 Thermo Fisher Scientific Business Overview
7.14.3 Thermo Fisher Scientific Precision Cancer Tests Introduction
7.14.4 Thermo Fisher Scientific Revenue in Precision Cancer Tests Business (2017-2022)
7.14.5 Thermo Fisher Scientific Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
